Home/Pipeline/Beremagene geperpavec-svdt (via Krystal Biotech)

Beremagene geperpavec-svdt (via Krystal Biotech)

Dystrophic Epidermolysis Bullosa

CommercialActive

Key Facts

Indication
Dystrophic Epidermolysis Bullosa
Phase
Commercial
Status
Active
Company

About GENESIS Pharma

GENESIS Pharma is a leading regional commercial partner in Central and Eastern Europe, dedicated to bringing innovative biopharmaceuticals and orphan drugs to patients. With nearly three decades of experience, the company has built a strong network of subsidiaries across the CEE region and strategic alliances with global biopharma innovators. Its business model centers on in-licensing and commercializing advanced therapies for chronic and rare diseases, making it a critical access channel for groundbreaking treatments in its markets.

View full company profile